Delivered 2023 Second-Quarter Reported Diluted EPS of $1.01 and Adjusted Diluted EPS of $1.60, Representing Currency-Neutral Growth of 16.9%; Targets 2023 Full-Year Reported Diluted EPS of $5.36 to...

Related Keywords

China , Russia , Japan , Kharkiv , Kharkivs Ka Oblast , Ukraine , Lviv , L Vivs Ka Oblast , Bangladesh , Spain , Italy , Indonesia , Sweden , Brazil , South Korea , United Kingdom , Australia , Turkey , Algeria , Mexico , Canada , Poland , Egypt , Argentina , Germany , France , Philippines , Pakistan , Swedish , Ukrainian , Russian , South Korean , Vectura Fertin Pharma , Jacek Olczak , Emmanuel Babeau , European Commission , Drug Administration , Philip Morris International , Philip Morris Korea Inc , Philip Morris International Inc , International Market Share , International Share Of Market , Supreme Court , International Duty Free , Regulatory News , Morris International , Product Shipment Volume , Free Product Net Revenues , Total Net Revenues , Diluted Earnings , Swedish Match , Chief Executive , Middle East , Year Forecast , Cautionary Statements , Premarket Tobacco Product Application , Heating System , Modified Risk Tobacco Product , Tobacco Harm , Investor Day , Healthcare Reporting Segment Asset Impairment , Philip Morris Korea , South Korean Board , Chief Financial Officer , Eastern Time , Southeast Asia , Independent States , Europe Region , Americas Region , East Asia , Cigarette Market Share , Ended June , Research Costs , Months Ended June , Net Revenues , Market Share , Fertin Pharma , Operating Income , Modified Risk Tobacco Products , Private Securities Litigation Reform Act , Quarterly Report , Total Market , Markets ,